Oppenheimer Downgrades Teva Pharma (TEVA) to Perform
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Oppenheimer downgraded Teva Pharma (NYSE: TEVA) from Outperform to Perform and removed its price target (prior $72.00).
Shares of Teva Pharma closed at $55.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Cuts Teva Pharma (TEVA) to Neutral Amid Challenging Generic Environment
- Generics File Against New Teva Pharma (TEVA) Copaxone 40MG Patent - Evercore ISI
- Jefferies Downgrades NantKwest (NK) to Hold
Create E-mail Alert Related CategoriesDowngrades, Hot Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!